Giessen

EQS-News: Jalin Ketter appointed CEO of PVA TePla

Retrieved on: 
Thursday, December 14, 2023
Supervisory board, Spokesperson, Head, Islamabad Wildlife Management Board, Capital market, CFO, PVA, Management, Property management, Giessen

Jalin Ketter will take over as CEO of PVA TePla AG on 1 January 2024.

Key Points: 
  • Jalin Ketter will take over as CEO of PVA TePla AG on 1 January 2024.
  • The Supervisory Board has thus entrusted Jalin Ketter with long-term management responsibility for PVA TePla.
  • "The decision to appoint Jalin Ketter as CEO not only recognizes her impressive expertise and leadership skills, but also her many years of valuable work for PVA TePla," explains Alexander von Witzleben, Chairman of the Supervisory Board of PVA TePla.
  • The Supervisory Board had already appointed Jalin Ketter as Spokesperson of the Management Board last July as part of the reorganization of the Group's top management.

Hill+Knowlton Appoints Geraldine Schroeder as CEO, Germany

Retrieved on: 
Wednesday, September 13, 2023
Professional Services, Marketing, Business, Communications, Consulting, Media, Public Relations, Investor Relations, Communication, Journalism, University, University of London, German Council on Foreign Relations, BBC, Annamaria, Institute of technology, Politics, Hill+Knowlton Strategies, SAT.1, WPP, Multimedia, Technical University of Berlin, History, Photograph, Acquisition, Investment, DGAP, ENGIE, Foreign policy, Giessen, Growth, Voith, Management, Vattenfall

Hill+Knowlton Strategies, one of the world’s leading strategic communications companies, today announced the appointment of Geraldine Schroeder as its new CEO, Germany, effective October 9, 2023.

Key Points: 
  • Hill+Knowlton Strategies, one of the world’s leading strategic communications companies, today announced the appointment of Geraldine Schroeder as its new CEO, Germany, effective October 9, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230913241179/en/
    Hill+Knowlton Appoints Geraldine Schroeder as CEO, Germany.
  • In the past three years, as CEO of Grayling in Germany, she successfully expanded the agency's portfolio.
  • On the client side, Schroeder acquired deep expertise in the energy and industrials sectors, with a focus on advancing the transition toward renewable energies.

EQS-News: RHÖN-KLINIKUM AG looks back on successful Q1 2023

Retrieved on: 
Thursday, May 11, 2023
News, Partnership, Bed, Health in the Federated States of Micronesia, Teaching, COVID-19, University, Tax, Asclepius, Research, Person, EBITDA, Patient, Giessen, Nursing, Assessment, Depreciation, Federalism, Health, Adjustment, Security (finance), Hospital

RHÖN-KLINIKUM AG, one of the largest healthcare providers in Germany, has made a good start into the new financial year.

Key Points: 
  • RHÖN-KLINIKUM AG, one of the largest healthcare providers in Germany, has made a good start into the new financial year.
  • In the first three months of financial year 2023, the Group of RHÖN-KLINIKUM AG recorded revenues of 361.5 million euros after 347.3 million euros in the same period of the previous year.
  • From January to March we treated 228,189 patients, 6.5 per cent more than in the same period last year (previous year Q1 2022: 214,321).
  • www.rhoen-klinikum-ag.com
    RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale
    11.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

DGAP-News: RHÖN-KLINIKUM AG looks back on successful financial year 2021

Retrieved on: 
Friday, April 1, 2022
EBITDA, 2009 Davis Cup, Company, Asclepius, Giessen, Investment, Group, University, Legislation, Board, Letter, MVZ, Education, Research, Hospital, Workload, Nursing, Investor, Hesse, Consolidated, Federalism, Person, Hope, Intention, COVID-19, DRG, Patient, Partnership, Medicine, Health insurance

For RHN-KLINIKUM AG, financial year 2021 was also marked by the COVID-19 pandemic and a big test of its strength and resilience.

Key Points: 
  • For RHN-KLINIKUM AG, financial year 2021 was also marked by the COVID-19 pandemic and a big test of its strength and resilience.
  • In financial year 2021, revenues grew by 3.1 per cent to reach 1.4 billion.
  • For the current financial year, we expect revenues of 1.4 billion euros within a range of plus or minus 5 per cent.
  • RHN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.

Ulrich Thienel MD, PhD Named Chief Executive Officer of ReAlta Life Sciences, Inc.

Retrieved on: 
Monday, August 26, 2019
Biotechnology, Pharmaceutical, Health, Learned societies, Giessen, Grand Duchy of Hesse, Justus von Liebig, States of Germany, National academies

Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors as Chief Executive Officer, effective September 1, 2019.

Key Points: 
  • Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors as Chief Executive Officer, effective September 1, 2019.
  • Ulrich was formerly Chief Medical Officer at Finch Therapeutics, Boston.
  • Ulrich received his MD and PhD degrees at Justus-Liebig University in Giessen, Germany and also completed training in Internal Medicine.
  • His leadership and insights will be invaluable in helping ReAlta to develop our platform of life saving pharma products.